Basic info
Industry
biotechnology research
Sectors
Biotechnology
Neurodegenerative Diseases
MND
Lou Gehrig's Disease
ALS
CNS
Parkinson's Disease
Biopharmaceuticals
Neuroscience
Novel treatment
Drug Development
Alzheimer's disease
Date founded
2017
Funding rounds raised
Total raised
$529K
from 1 investors over 1 rounds
N
NeuroSense Therapeutics raised $529K on February 1, 2020
Investors: PipelBiz